The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
A solid update today, a lot to be excited about and great to see more leads and already likely revenue - wouldn’t be surprised if a division is sold off down the line.
Singer rated Onc as a ‘best idea for 2021’ and reiterated it after today with an intrinsic value of 271p.
The sp may not be where we want it to be but confident in the future outcome!
Surprised for such a large drop, yes there has been sales today but not loads, and not for huge volumes either! One would assume just some profit taking but annoying it has led to such a drop - good margin between buy and sell though. Can only assume the price will rally by EOD.
Some news would be nice, hopefully any CDT updates with NHS are not far away - that being said still no concerns, happy to let this one bubble away!
Couldn’t agree more Gilers. Trek also agree - very odd given the sharp rise over the last year that more haven’t jumped in, that being said I don’t mind and the educated posts is a very nice thing.
I guess we know what is coming up so no real need to post unless there is news or worthy, relevant information. I am interested to see where we finish, still playing on my mind as to whether we will see £10 or get acquired beforehand!
Apologies for going off topic but 4D is an odd one, should be higher and some shorts against it but I’ll go nowhere for the medium term as MD putting 7 figures of his own money in says a lot.
Open Orphan is different, the CEO is extremely charismatic. Some incredibly interesting spin offs especially Disease in Motion which could be a goldmine!
GLA
Hi all,
No much of a poster but keep track of the boards, on others like Orph or 4D it can get a bit tense but here is very structured and reasonable so will try to post more often.
Great posts below, agree PC a fantastic ride so far and much more to come.
Very keen to see what happens with NHS deals, could really put us on the map and massively help the financials!
Have a lovely Sunday.
Good shout on the placing Trek, I did not think it would happen but I was wrong!
Seems to be a nice (and quick!) drive to get US sales off the ground with a US listing down the line and specifically trying to grow the sales team out.
With the insti's adding I'd like to think we won't be prone to any dips below 180 or so and will see some levelling when there is no news!
A few contracts in before financial year end will be a welcome bonus (specifically CDT with the NHS), but as I said before happy with this investment and as igrowmoney said there is much less risk here. Sadly I already have a considerable amount here so can't top much up (at least not for now), but will likely use Onc and Orph for my ISA allocation!
Slowly but surely (at least compared to some companies that for some reason seem to swell at minimal news!) we are getting there, happy to keep under the radar for now, my only question is will we ever see this company get to the great heights we all expect/ hope or will one of the large pharmas just buy Onc out (I'd expect £5-6?).
GLA
5 tiny trades today and a near 5% drop in the SP, madness!
David1951c - I'd hope for more than £3 by the end of the year with all of the deals in the pipeline but we will wait and see.
Not going anywhere, just a tad annoyed by the drastic change in SP from such small volumes, something is happening..
I can’t see there being an insti offload due to the volume? SP making zero sense at the moment so something is going on, fairly large moves off such little volume. Topped up at 185 and already holding a lot here so nothing more from me. SP now seems to have moved back to where it was from one larger trade though.
We were expecting news before end of March, so hopefully a RNS this week! I wait with bated breath.
When do director options kick in, was it £3?
Still no concerns just annoyed by movement, but the world moves in mysterious ways!
iPhone - Agree on ONC being cheap, though I don’t mind as I topped up again.
As for the news aspect, more than confident in the business so lack of news is not worrying (not that you are! :D).
News will come, personally I’m happy atm with the lack of trades - less illiquid and means people are confident! It’s still a highly undervalued stock, I do enjoy knowing I don’t need to check this one regularly.
Early CDT for me is the USP, just doing the maths on those tests blows my mind!
Funny how we seem to be invested in similar, stocks - Onc since 70p , Orph since 16p, 4D since 96p, I've topped up on all so sadly not my avg buy in but can't complain!
Of all of them this for me is the best bet (although Open Orphan could soar if all goes to plan), Trek you outline a number of key points, great to see a number of us are on the same page here. For me I'm most excited to hear about the EarlyCDT evaluation with contracts with NHS expected to be completed within 12 months.
It's a shame a NASDAQ listing isn't considered, how we would fly then! Very much enjoy the limited number of shares on the market, it may not move at a rapid pace but it goes up nicely. Sadly I don't think we will ever see this share get to a deserved £10, will likely be sold to one of the big boys for half that price probably by the end of the year. Director options are VERY hugely deserved!